Cargando…

Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autores principales:	Richter, Manuel J., Tello, Khodr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049925/ https://www.ncbi.nlm.nih.gov/pubmed/31726011 http://dx.doi.org/10.1164/rccm.201910-2069ED

Ejemplares similares

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Cardiac magnetic resonance imaging and clinical prognosis in pulmonary arterial hypertension
por: Junqueira, Flávia Pegado, et al.
Publicado: (2019)

Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
por: Lewis, Robert A., et al.
Publicado: (2020)

Cardiac magnetic resonance imaging in pulmonary arterial hypertension
por: Peacock, Andrew J., et al.
Publicado: (2013)

Myocardial Delayed Enhancement by Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: A Marker of Disease Severity
por: Rochitte, Carlos Eduardo, et al.
Publicado: (2013)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
por: Humbert, Marc, et al.
Publicado: (2021)

Assessment of Pulmonary Arterial Hypertension by Magnetic Resonance Imaging
por: Ibrahim, El-Sayed H., et al.
Publicado: (2015)

Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?
por: Kjellström, Barbro, et al.
Publicado: (2020)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
por: Grimminger, Jan, et al.
Publicado: (2017)

The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting?
por: Wessels, Jeroen N., et al.
Publicado: (2020)

Against all odds
por: Nichani, Ashish Sham
Publicado: (2011)

The role of cardiac magnetic resonance imaging in the assessment of right ventricular function in patients with pulmonary arterial hypertension
por: Mouratoglou, Sophia-Anastasia, et al.
Publicado: (2015)

Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies
por: Vidal-Perez, Rafael, et al.
Publicado: (2023)

Cardiac Magnetic Resonance in Pulmonary Hypertension—an Update
por: Alabed, Samer, et al.
Publicado: (2020)

Multiparameter use of Cardiac Magnetic Resonance as a predictor of pulmonary artery hypertension
por: Avery, Ryan, et al.
Publicado: (2016)

Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension
por: Blalock, Shannon, et al.
Publicado: (2013)

Severe Pulmonary Arterial Hypertension: Comprehensive Evaluation by Magnetic Resonance Imaging
por: Ibrahim, El-Sayed H., et al.
Publicado: (2015)

Magnetic resonance phase contrast imaging in children with pulmonary artery hypertension
por: Fonseca, Brian, et al.
Publicado: (2009)

Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension
por: Sommer, Natascha, et al.
Publicado: (2022)

Right ventricular dyssynchrony: from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Multiparametric Cardiac Magnetic Resonance Imaging for Diagnosing Cardiac Allograft Vasculopathy
por: Lee, Ji Won
Publicado: (2022)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension
por: Rieth, Andreas J., et al.
Publicado: (2022)

Clinically important changes in right ventricular volume and function in pulmonary arterial hypertension assessed with cardiac magnetic resonance imaging
por: Göransson, Christoffer, et al.
Publicado: (2022)

Quantification of Cardiac Output with Phase Contrast Magnetic Resonance Imaging in Patients with Pulmonary Hypertension
por: Po, Jose Ricardo, et al.
Publicado: (2020)

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Novel biomarkers for risk stratification in pulmonary arterial hypertension
por: Zelniker, Thomas, et al.
Publicado: (2015)

Risk stratification and medical therapy of pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
por: Vraka, Argyro, et al.
Publicado: (2023)

Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension
por: Grignola, Juan C., et al.
Publicado: (2021)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Cardiac Magnetic Resonance for Ventricular Tachycardia Ablation and Risk Stratification
por: Roca-Luque, Ivo, et al.
Publicado: (2022)

Cardiac magnetic resonance imaging; gatekeeper in suspected CAD?
por: van der Wall, E. E., et al.
Publicado: (2010)

Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification
por: Korosoglou, Grigorios, et al.
Publicado: (2014)

Non-Invasive Cardiac Output Determination Using Magnetic Resonance Imaging and Thermodilution in Pulmonary Hypertension
por: Crowe, Lindsey A., et al.
Publicado: (2022)

Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension
por: Goh, Ze Ming, et al.
Publicado: (2021)

Lack of concordance between the different exercise test measures used in the risk stratification of patients with pulmonary arterial hypertension
por: Mora Cuesta, Víctor M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_664155qce2end43tlasge92rlk